LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
Hotels and Motels for Sale
Wholesale & Distribution Businesses for Sale
Consulting & Training Businesses for Sale
Finance & Accounting Businesses for Sale
Post Office Businesses for Sale
Banquet Halls & Catering Businesses for Sale
Retail Businesses for Sale
Beauty & Personal Care Businesses for Sale
Manufacturing Businesses for Sale
Real Estate & Property Management Companies for Sale
Finance & Accounting Franchise Opportunities
Convenience Store & Lotto Franchises for Sale
Employment & Personnel Franchise Opportunities
Service Franchises for Sale
Smoke & Vape Shop Franchises for Sale
Transport & Shipping Franchise Opportunities
Entertainment & Recreation Franchise Opportunities
Miscellaneous Franchises for Sale
Printing, Signs & Publishing Franchise Opportunities
Pet Franchise Opportunities
Plazas for Sale
Places of Worship for Sale
Commercial Spaces for Sale or Lease
Apartment Buildings for Sale
Commercial Buildings for Sale or Lease
Mixed Use Buildings for Sale or Rent
Houses & Condos for Sale or Lease
Medical Office Spaces for Sale or Rent
Industrial Units for Sale or Rent
Land & Developments for Sale
An email will be sent to registered email address.
Please select if you are: